Modern digital technologies can build in traceability from development to commercialization to optimize outcomes. As cell and gene therapy makes inroads in the life sciences marketplace, an important existing concept from this space has begun to draw more attention than it had previously: traceability.
Emerson’s Director of Life Sciences Strategy Michalle Adkins and Bob Lenich, business director of Emerson’s industrial software business share their thoughts in this article in Pharma Manufacturing magazine on traceability to ensure product efficacy.